The cancer driver molecule AKT in pancreatic cancer cells (VIDEO)

Garvan Institute of Medical Research

Caption

Left: the cancer driver molecule AKT (blue) switched on in pancreatic cancer cells. Right: a treatment targeting AKT is administered, but the molecule remains active in distinct pockets (blue). The researchers aim to next target these drug resistant pockets using combination treatment.

Credit

Max Nobis (VIB-KU Leuven Center for Cancer Biology)

Usage Restrictions

Credit must be given to the creator. Adaptations must be shared under the same terms.

License

CC BY-SA

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.